Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313583 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Xiaona Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Statistics, Southwest University, Chongqing, China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Nutrition Surveys, Fractures, Bone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
The relationship between statin treatment and fracture risk is still controversial, especially in in patients with cardiovascular diseases (CVDs). We aim to determine whether statin therapy affects the occurrence of fractures in the general US population and in patients with CVDs.
Methods
Epidemiological data of this cross-sectional study were extracted from the National Health and Nutrition Examination Survey (NHANES, 2001–2020, n = 9,893). Statins records and fracture information were obtained from the questionnaires. Weighted logistic regressions were performed to explore the associations between statin and the risk of fracture.
Results
Statin use was found to be associated with reduced risk of fracture mainly in male individuals aged over 50 years old and taking medications for less than 3 years, after adjusted for confounders including supplements of calcium and vitamin D. The protective effects were only found in subjects taking atorvastatin and rosuvastatin. We found null mediation role of LDL-C and 25(OH)D in such effects. Statin was found to reduce fracture risk in patients with cardiovascular diseases (CVDs, OR: 0.4366, 95%CI: 0.2664 to 0.7154, P = 0.0014), and in patients without diabetes (OR: 0.3632, 95%CI: 0.1712 to 0.7704, P = 0.0091).
Conclusions
Statin showed advantages in reducing risk of fracture in male individuals aged over 50 years old and taking medications for less than 3 years. More research is needed to determine the impact of gender variations, medication duration, and diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Mathematics and Statistics, Southwest University, Chongqing, China.
- Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center…
- Department of Urology Surgery, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Nursing, Daping Hospital, Army Medical University, Chongqing, China.
ORCID-Profile: Qiang Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, X., Liu, X., Wang, C., Luo, Y., Li, X., Yan, L., Wang, Y., Wang, K., & Li, Q. (2024). Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey. PLOS ONE. https://doi.org/10.1371/journal.pone.0313583
Vancouver
Sun X, Liu X, Wang C, Luo Y, Li X, Yan L, et al. Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey. PLOS ONE. 2024. doi:10.1371/journal.pone.0313583
BibTeX
@article{Sun2024,
author = {Sun, Xiaona and Liu, Xiaoxiao and Wang, Chenyi and Luo, Yushuang and Li, Xinyi and Yan, Lijuan and Wang, Yaling and Wang, Kaifa and Li, Qiang},
title = {Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313583}
}
EUVIMED